Home
Business News
European Commission Approves Opdivo (nivolumab) Four-Week Dosing Schedule for the Adjuvant Treatment of Adult Patients with Melanoma with Involvement of Lymph Nodes or Metastatic Disease Who Have Undergone Complete Resection
Related Posts
Please leave this field emptyGet every new post delivered right to your inbox. Email * Check your inbox or spam…
Duke Energy Florida has launched an innovative ‘Bring Your Own Battery’ study to test potential enhancements to the energy grid…
Duke Energy Foundation has awarded the Richland Volunteer Fire Department a $12,000 Duke Energy Sustainable Solutions grant to help the…
TARRYTOWN, N.Y. and WASHINGTON , Jan. 20, 2022 /PRNewswire/ — Over $3 Million to be Awarded in Oldest and…
Please leave this field emptyGet every new post delivered right to your inbox. Email * Check your inbox or spam…
Software reduces harmful emissions and fuel consumption with Artificial Intelligence /Machine Learning enabled continuous tuning for gas turbines Lower total…
Team-based health care group that serves Medicare patients from a wide range of health plans to open 26 new centers…
Feb. 3 at 4:30 p.m. EST IRVINE, Calif. –(BUSINESS WIRE)–Jan. 20, 2022– Skyworks Solutions, Inc. (Nasdaq: SWKS), an innovator of…
Spruce addresses significant unmet needs around spending, saving, and planning KANSAS CITY, Mo., Jan. 20, 2022 (GLOBE NEWSWIRE) — Living…
Please leave this field emptyGet every new post delivered right to your inbox. Email * Check your inbox or spam…